Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging

Article Oncology

Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study

Sven H. Loosen et al.

Summary: This study analyzed the clinical characteristics of gastrointestinal neuroendocrine tumors (GI-NETs) in four European countries and found regional differences in age distribution, tumor site, and grading.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades

Kaili Yang et al.

Summary: This study aimed to illustrate the current landscape of clinical trials in GEP-NENs and provide insights for future research. The study found that most trials were conducted in high-income countries, had low result reporting rates, and had a long time from completion to result reporting. In recent years, trials have placed more emphasis on specifying inclusion criteria and international collaborations.

ENDOCRINE CONNECTIONS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The potential application of MR-derived ADCmin values from 68Ga-DOTATATE and 18F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors

Jing Gao et al.

Summary: A retrospective study was conducted on 46 patients with histologically confirmed PNETs using Ga-68-DOTATATE and F-18-FDG PET/MR imaging, revealing correlations between FDG PET-derived parameters and ADCmin. FDG PET parameters can be used as predictive tools for the grade and stage of PNETs, and ADCmin may serve as an alternative to FDG PET for grading and staging.

EJNMMI RESEARCH (2023)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists

Fabio Pellegrino et al.

Summary: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of tumors that arise from cells of the diffuse neuroendocrine system. They can be sporadic or occur in the context of genetic syndromes. They are mostly nonfunctioning, but some produce hormones responsible for clinical syndromes. The grade and differentiation of the tumor can affect clinical behaviors and prognoses. Diagnosis of GEP-NENs involves identifying the presence of the tumor and determining the primary site and extent of metastases. Morphological evaluations, such as CT and MRI, and functional evaluations, such as PET-CT and somatostatin analogs, are important in the diagnostic management of patients.

TOMOGRAPHY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms

Mohammed Saleh et al.

Summary: This article illustrates the applications of various imaging tools to diagnose, stage, grade, prognosticate, plan treatment and assess treatment response in cases of pancreatic neuroendocrine neoplasms (PNENs).

ABDOMINAL RADIOLOGY (2022)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review

Samuel J. Galgano et al.

Summary: Neuroendocrine neoplasms (NENs) are a diverse group of tumors with various treatment options. Precise criteria for treatment response in NENs are lacking and different imaging modalities have different strengths and weaknesses in evaluating therapy response. Further definition of standardized assessment criteria for tumor response and progression is needed.

AMERICAN JOURNAL OF ROENTGENOLOGY (2022)

添加到收藏夹

Article Oncology

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms

Daisuke Takayanagi et al.

Summary: This review provides updates on the epidemiology, diagnosis, and management of gastroenteropancreatic neuroendocrine neoplasms. The incidence of these malignancies originating from the pancreatic and gastrointestinal neuroendocrine cell system has been increasing. Advances in molecular diagnosis, treatment strategies, and liquid biopsy have contributed to personalized management for patients.

CANCERS (2022)

添加到收藏夹

Review Oncology

State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors

Apostolis Papaefthymiou et al.

Summary: Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are a heterogeneous group of tumors arising from the neuroendocrine cells of the gastrointestinal tract. The incidence of GEP NENs is increasing, possibly due to the more frequent use of endoscopy and imaging studies for diagnosis. The management of these tumors should be guided by a multidisciplinary team and appropriate staging investigations.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)

添加到收藏夹

Review Oncology

New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms

Emilia Fortunati et al.

Summary: Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumors that can occur anywhere in the human body. PET radiopharmaceuticals, such as 68Ga-DOTA-peptides, can be used for the diagnostic assessment of NEN. SSTR imaging is recommended for assessing disease extension, follow-up, response to therapy, and selecting patients for radionuclide therapy. New tracers and theranostic pairs provide potential diagnostic and therapeutic options for NEN patients.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms

Ajaykumar C. Morani et al.

Summary: This study assessed the accuracy of multidetector computed tomography (MDCT) in detecting gastrointestinal neuroendocrine neoplasms (NENs) and compared the effectiveness of negative and positive enteric contrast in detecting at least one tumor per patient.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Feng Yin et al.

Summary: This article reviews the recent advances in the clinical presentation, diagnosis, and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), including histopathologic classification, tumor grading and staging system, molecular genetics, and the application of novel therapeutic approaches. These findings will contribute to improving patient care by enabling precise diagnosis and individualized treatment of GEP-NENs.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

Jiayun M. Fang et al.

Summary: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are tumors that originate from neuroendocrine cells in the gastrointestinal tract and pancreas. The incidence of GEP-NENs is increasing due to improved awareness and diagnostic techniques. GEP-NENs are a heterogeneous group of tumors, and their clinical presentation and molecular biology can vary greatly. The World Health Organization has recently updated the classification of GEP-NENs, introducing a distinction between high-grade neuroendocrine tumors and neuroendocrine carcinomas. This article discusses the clinical features and updates in the diagnosis of GEP-NENs, including histopathological analysis, biomarkers, molecular techniques, and radiology.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Meng Dai et al.

Summary: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors originating from neuroendocrine cells of the digestive system. Their incidence is increasing, and many patients are diagnosed at later stages. Recent research has focused on improving diagnosis and treatment, resulting in significant progress in clinical practice.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2022)

添加到收藏夹

Review Oncology

Prognostic value of CT characteristics in GEP-NET: A systematic review

D. L. van der Velden et al.

Summary: This systematic review provides an overview of the available literature on CT characteristics and their prognostic significance for GEP-NET patients. The findings suggest that larger tumor size, hypo-enhancement, irregular shape and ill-defined margins, presence of locally invasive growth, lymphadenopathy and metastases are predictors of poorer prognosis.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

添加到收藏夹

Article Surgery

Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma

Alaa Sada et al.

Summary: Patients with MEN-1 insulinomas present at a younger age with larger benign pancreatic lesions compared to patients with sporadic neoplasms. Evaluation for MEN-1 should be considered in younger patients and those with multifocal pancreatic neuroendocrine tumors in the setting of endogenous hyperinsulinism.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2022)

添加到收藏夹

Review Medicine, General & Internal

Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update

Daniela Prosperi et al.

Summary: This narrative review discusses the use of different imaging techniques in the management of pancreatic neuroendocrine neoplasms (panNENs). Ga-68-somatostatin analogues (SSA) PET/CT is the most commonly used imaging method, while F-18-Fluordeoxiglucose (FDG) PET/CT is preferred in certain cases. The combination of Ga-68-SSA PET/CT and F-18-FDG PET/CT can assist in determining the best therapeutic strategy. Other radiopharmaceuticals and radiomics are also being explored for the management of panNENs.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Medicine, General & Internal

Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update

Efstathios Theodoros Pavlidis et al.

Summary: The prevalence of gastrointestinal neuroendocrine tumors is increasing, and the current therapy is inadequate. There is ongoing debate on diagnostic criteria and clinical behavior, and new diagnostic tools and treatment methods are promising. Surgery plays a crucial role in management.

WORLD JOURNAL OF CLINICAL CASES (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Detection of Bone Metastases by 68Ga-DOTA-SSAs and 18F-FDG PET/CT: A Two-Center Head-to-Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms

Rui Tian et al.

Summary: This study assessed the efficacy of dual-tracer PET/CT imaging for detecting bone metastases in patients with GEP-NENs. The results showed that Ga-68-DOTA-SSAs were superior to F-18-FDG for detecting bone metastases in both well/moderately differentiated and poorly differentiated NETs. The imaging results were also correlated with tumor differentiation.

CONTRAST MEDIA & MOLECULAR IMAGING (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Analysis of Clinical Characteristics and Survival in Patients With Functional Neuroendocrine Tumors of Gastrointestinal Origin

Anahat Kaur et al.

Summary: Functional neuroendocrine tumors (FNETs) are more common in White patients older than 50 years, with gastrinoma and insulinoma being the most common types. Surgery is the primary treatment modality, with a median overall survival of 9.8 years and a median cancer-specific survival of 18.5 years. Age, surgical resection, metastasis, and poor differentiation are important prognostic factors for patient survival.

PANCREAS (2022)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Neuroendocrine neoplasm imaging: protocols by site of origin

Sooyoung Martin et al.

Summary: This article presents recommended CT and MRI imaging protocols for gastro-enteric and pancreatic neuroendocrine neoplasms, based on the site of origin or predominant pattern of metastatic disease. The rationale for MRI contrast type, timing, and specific sequences is explained. Brief comments are also provided on PET/CT and PET/MRI imaging protocols.

ABDOMINAL RADIOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade

Giuditta Chiti et al.

Summary: The study aims to evaluate the predictive ability of contrast-enhanced computed tomography (CECT) radiomics analysis in grading GEP-NENs according to the 2019 WHO classification and to establish a tumor grade prediction model. The results suggest that CT-radiomics analysis can aid in differentiating the histological grade of GEP-NENs.

RADIOLOGIA MEDICA (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PET/CT and PET/MRI in neuroendocrine neoplasms

Naveen Rajamohan et al.

Summary: Advanced molecular imaging, especially somatostatin receptor PET, has become essential in the management of GEP-NENs. SSTR PET/MRI with liver-specific contrast agent shows strong potential for comprehensive evaluation of GEP-NENs. The development of novel radiotracers can address the existing limitations in molecular imaging of GEP-NENs, and quantitative evaluation of molecular imaging studies is an active research area.

ABDOMINAL RADIOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Gastric neuroendocrine neoplasms: a primer for radiologists

Molly E. Roseland et al.

Summary: Gastric neuroendocrine neoplasms are rare tumors with variable differentiation and malignant potential. They can be categorized into three subtypes, each requiring different diagnostic and management approaches. Understanding the pathophysiology and histologic classifications is crucial for effective imaging, therapy, and prognosis assessment.

ABDOMINAL RADIOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms

Servane Gay-Chevallier et al.

Summary: This study aimed to describe the management and prognosis of nonmetastatic duodenal neuroendocrine neoplasms (dNEN) patients. The results showed that selected nonmetastatic dNEN had a favorable outcome, and a less invasive therapeutic strategy appeared more suitable than oncological surgery for some patients.

NEUROENDOCRINOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Recurrence and Survival of Neuroendocrine Neoplasms of the Rectum: Single-Center Experience

Alessandra Storino et al.

Summary: Patients with small, low grade rectal NENs treated with local excision have excellent oncologic outcomes, with low recurrence rate and high survival rate.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

Tetsuhide Ito et al.

Summary: Neuroendocrine neoplasms (NENs) are rare tumors with diverse clinical manifestations. Accurate pathological classification and determination of tumor characteristics are crucial for selecting appropriate treatment strategies. The revised Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) provide comprehensive directions for the management of NENs, incorporating new evidence and updated concepts.

JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Added value of [68Ga]Ga-DOTA-TOC PET/CT for characterizing pancreatic neuroendocrine neoplasms: a comparison with contrast-enhanced CT and/or MRI in a large study cohort

Jeongin Yoo et al.

Summary: The study demonstrated that [Ga-68]Ga-DOTA-TOC PET/CT provided additional diagnostic value for characterizing suspected pancreatic NENs compared to conventional CT or MRI. Radiologists' diagnostic performance significantly improved with the addition of [Ga-68]Ga-DOTA-TOC PET/CT.

EUROPEAN RADIOLOGY (2021)

添加到收藏夹

Review Oncology

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses

Giorgio Treglia et al.

Summary: Ga-68-SSA PET shows high diagnostic performance for NETs and PGL; F-18-FDOPA PET demonstrates good diagnostic performance for intestinal NETs, PGL, and NB; Ga-68-exendin-4 PET has good diagnostic accuracy in detecting insulinomas.

CANCERS (2021)

添加到收藏夹

Review Oncology

Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?

Satya Das et al.

Summary: The purpose of the review is to explore global epidemiologic trends of gastroenteropancreatic neuroendocrine tumors (NETs), looking at differences in incidence, prevalence, distribution, and overall survival between different regions. GEP NET incidence rates are rising steadily in North America, Asia, and Europe, with differences in distribution of NETs among regions. Improved overall survival for GEP NET patients is also observed over time.

CURRENT ONCOLOGY REPORTS (2021)

添加到收藏夹

Review Pathology

Counting mitoses: SI(ze) matters!

Ian A. Cree et al.

Summary: Mitoses in cancer diagnosis are often assessed by counting per square millimeter, but the variation in microscope fields, especially in digital pathology systems, can lead to errors. Standardized international units should be used to ensure accuracy in mitotic count.

MODERN PATHOLOGY (2021)

添加到收藏夹

Article Oncology

Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort

Oddry Folkestad et al.

Summary: Neuroendocrine tumours of the upper small intestine are rare, slow growing, and can be treated with endoscopic removal or surgery. Long-term survival is associated with tumor growth rate and complete tumor removal, with larger tumors potentially requiring surgery for lymph node metastases. Patients with these tumors generally have long overall survival, and both endoscopic and surgical resections have shown effective results with low recurrence rates.

CANCERS (2021)

添加到收藏夹

Review Medicine, General & Internal

Gastric neuroendocrine neoplasms: A review

Huseyin Koseoglu et al.

Summary: Gastric neuroendocrine neoplasms are slow-growing tumors with increasing incidence, divided into four types based on clinical features, each with different management and prognosis. Diagnosis requires histopathological investigation, and treatment options include surgery, medication, and chemotherapy.

WORLD JOURNAL OF CLINICAL CASES (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?

Klaire Exarchou et al.

Summary: Localized grade 1 or 2 type III gastric neuroendocrine neoplasms (g-NENs) have a good prognosis, with tumor size greater than 10 mm being the most significant prognostic factor impacting patient outcomes. Endoscopic resection or limited surgical resection is feasible and safe for small type III g-NENs with favorable grade 1/2, well differentiated histology.

ENDOCRINE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Appendiceal neuroendrocrine neoplasms: incidentaloma or something we should worry about?

Laurence Lousberg et al.

CURRENT OPINION IN GASTROENTEROLOGY (2020)

添加到收藏夹

Article Oncology

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

Manuel Weber et al.

BMC CANCER (2020)

添加到收藏夹

Review Nutrition & Dietetics

The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition

Jakub Poblocki et al.

NUTRIENTS (2020)

添加到收藏夹

Article Surgery

Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors

Norifumi Harimoto et al.

WORLD JOURNAL OF SURGERY (2020)

添加到收藏夹

Review Surgery

Pancreatic neuroendocrine tumours: spectrum of imaging findings

Eleonora Bicci et al.

GLAND SURGERY (2020)

添加到收藏夹

Article Oncology

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Esben Andreas Carlsen et al.

ENDOCRINE-RELATED CANCER (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The Correlation Between [68Ga]DOTATATE PET/CT and Cell Proliferation in Patients With GEP-NENs

Jiangyuan Yu et al.

MOLECULAR IMAGING AND BIOLOGY (2019)

添加到收藏夹

Article Surgery

Evaluation and Management of Neuroendocrine Tumors of the Pancreas

Aaron T. Scott et al.

SURGICAL CLINICS OF NORTH AMERICA (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study

Francesco Panzuto et al.

DIGESTIVE AND LIVER DISEASE (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study

Dongsheng Gu et al.

EUROPEAN RADIOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE

Christoph Wetz et al.

PLOS ONE (2019)

添加到收藏夹

Article Oncology

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes

S. Felder et al.

ENDOCRINE-RELATED CANCER (2019)

添加到收藏夹

Article Endocrinology & Metabolism

What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?

Benjamin G. Challis et al.

CLINICAL ENDOCRINOLOGY (2019)

添加到收藏夹

Article Oncology

A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors

Wenjie Liang et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis

Sue Ping Thang et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

添加到收藏夹

Review Oncology

Neuroendocrine neoplasms of rectum: A management update

Emilio Bertani et al.

CANCER TREATMENT REVIEWS (2018)

添加到收藏夹

Review Oncology

Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies

Lingaku Lee et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity

Roberta Elisa Rossi et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)

添加到收藏夹

Article Surgery

Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract

Jeffrey A. Norton et al.

JAMA SURGERY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases

Alessandro Vanoli et al.

NEUROENDOCRINOLOGY (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT

Lino M. Sawicki et al.

EUROPEAN RADIOLOGY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

Anders Sundin et al.

NEUROENDOCRINOLOGY (2017)

添加到收藏夹

Article Oncology

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari et al.

JAMA ONCOLOGY (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma

Jung Hoon Kim et al.

EUROPEAN RADIOLOGY (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging

Tobias Baumann et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Neuroendocrine tumors of the small bowel: evaluation with MR-enterography

Anthony Dohan et al.

CLINICAL IMAGING (2016)

添加到收藏夹

Article Oncology

Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites

Samira M. Sadowski et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies et al.

RADIOLOGY (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Management of gastric and duodenal neuroendocrine tumors

Yuichi Sato et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

添加到收藏夹

Review Gastroenterology & Hepatology

Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management

Jordan M. Cloyd et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

添加到收藏夹

Article Oncology

Comparison study of gastrinomas between gastric and non-gastric origins

Song-Fong Huang et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Incidental Neuroendocrine Tumors of the Pancreas: MDCT Findings and Features of Malignancy

Anna Gallotti et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas

Christine Schmid-Tannwald et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis

Hakan Geijer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Carcinoid tumors of the small-bowel: Evaluation with 64-section CT-enteroclysis

Philippe Soyer et al.

EUROPEAN JOURNAL OF RADIOLOGY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors Initial Results

Karsten J. Beiderwellen et al.

INVESTIGATIVE RADIOLOGY (2013)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging

Gaspard d'Assignies et al.

RADIOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Diagnosis and management of insulinoma

Takehiro Okabayashi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

添加到收藏夹

Article Oncology

Staging of neuroendocrine tumours: comparison of [68Ga]DOTATOC multiphase PET/CT and whole-body MRI

C. Schraml et al.

CANCER IMAGING (2013)

添加到收藏夹

Review Endocrinology & Metabolism

Neuroendocrine Neoplasms of the Gastroenteropancreatic System: Pathology and Classification

M. Anlauf

HORMONE AND METABOLIC RESEARCH (2011)

添加到收藏夹

Article Oncology

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

Martin B. Niederle et al.

ENDOCRINE-RELATED CANCER (2010)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pancreatic Endocrine Tumors: Radiologic-Clinicopathologic Correlation

Rachel B. Lewis et al.

RADIOGRAPHICS (2010)

添加到收藏夹

Article Endocrinology & Metabolism

A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: Identification of risk factors

Marc J. Berna et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Possible small-boweled neoplasms: Contrast-enhanced and water-enhanced multidetector CT enteroclysis

Frank Pilleul et al.

RADIOLOGY (2006)

添加到收藏夹

Review Gastroenterology & Hepatology

Endocrine tumours of the pancreas

K Öberg et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

MRI of pancreatic neuroendocrine tumours

NJ Owen et al.

BRITISH JOURNAL OF RADIOLOGY (2001)

添加到收藏夹

Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging

相关参考文献

导出引文

分享论文